A detailed history of Fmr LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 11,847 shares of AGIO stock, worth $531,574. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,847
Previous 4,970 138.37%
Holding current value
$531,574
Previous $145,000 251.72%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$27.55 - $48.83 $189,461 - $335,803
6,877 Added 138.37%
11,847 $510,000
Q1 2024

May 13, 2024

BUY
$21.32 - $34.81 $7,888 - $12,879
370 Added 8.04%
4,970 $145,000
Q4 2023

Feb 13, 2024

SELL
$19.97 - $24.53 $13,859 - $17,023
-694 Reduced 13.11%
4,600 $102,000
Q3 2023

Nov 13, 2023

BUY
$24.36 - $28.18 $6,625 - $7,664
272 Added 5.42%
5,294 $131,000
Q2 2023

Aug 11, 2023

SELL
$21.38 - $29.19 $577 - $788
-27 Reduced 0.53%
5,022 $142,000
Q1 2023

May 11, 2023

SELL
$21.74 - $30.93 $35.6 Million - $50.6 Million
-1,635,265 Reduced 99.69%
5,049 $115,000
Q4 2022

Feb 13, 2023

SELL
$24.81 - $31.52 $6.61 Million - $8.39 Million
-266,240 Reduced 13.96%
1,640,314 $46.1 Million
Q3 2022

Nov 10, 2022

SELL
$19.51 - $34.14 $20.1 Million - $35.1 Million
-1,029,288 Reduced 35.06%
1,906,554 $53.9 Million
Q2 2022

Aug 12, 2022

SELL
$17.06 - $31.42 $32.1 Million - $59.2 Million
-1,882,650 Reduced 39.07%
2,935,842 $65.1 Million
Q1 2022

May 13, 2022

SELL
$26.68 - $34.81 $16.4 Million - $21.4 Million
-615,822 Reduced 11.33%
4,818,492 $140 Million
Q4 2021

Feb 14, 2022

SELL
$29.58 - $49.78 $41.8 Million - $70.4 Million
-1,414,504 Reduced 20.65%
5,434,314 $179 Million
Q3 2021

Nov 15, 2021

SELL
$41.92 - $58.18 $51.7 Million - $71.7 Million
-1,233,192 Reduced 15.26%
6,848,818 $316 Million
Q2 2021

Aug 13, 2021

BUY
$52.06 - $61.27 $421 Million - $495 Million
8,082,010 New
8,082,010 $445 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.46B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.